M. Xiang

Most-cited papers

1. Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies.

   M. Xiang, P. Rybczynski, Mona Patel, Robert H. K. Chen +11 more

   2007Bioorganic & Medicinal Chemistry Letters17 citations Open access

   Semantic Scholar

   Save

2. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist.

   J. Gunnet, Pamela G Wines, M. Xiang, P. Rybczynski +8 more

   2008European Journal of Pharmacology11 citations

   Semantic Scholar

   Save

3. Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists.

   M. Xiang, Robert H. K. Chen, K. Demarest, J. Gunnet +5 more

   2004Bioorganic & Medicinal Chemistry Letters11 citations

   Semantic Scholar

   Save

4. Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists.

   M. Xiang, Robert H. K. Chen, K. Demarest, J. Gunnet +6 more

   2004Bioorganic & Medicinal Chemistry Letters6 citations Open access

   Semantic Scholar

   Save

5. Cyclopentene derivatives as motilinreceptorantagonister

   Robert H. K. Chen, M. Xiang, J. B. Moore, M. P. Beavers

   19980 citations

   Semantic Scholar

   Save